Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

Mateos, M.-V. ✉; Cavo, M.; Blade, J.; Dimopoulos, M.A.; Suzuki, K.; Jakubowiak, A.; Knop, S.; Doyen, C.; Lucio, P.; Nagy, Z. [Nagy, Zsolt (Belgyógyászat, en...), author] I. Department of Internal Medicine (SU / FM / C); Pour, L.; Cook, M.; Grosicki, S.; Crepaldi, A.; Liberati, A.M.; Campbell, P.; Shelekhova, T.; Yoon, S.-S.; Iosava, G.; Fujisaki, T.; Garg, M.; Krevvata, M.; Chen, Y.; Wang, J.; Kudva, A.; Ukropec, J.; Wroblewski, S.; Qi, M.; Kobos, R.; San-Miguel, J.